• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEntera Bio
    Picture of Entera Bio logo

    ENTX — Entera Bio News Story

    $3.020.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $525.25m
    • Enterprise Value
      $513.94m
    • Revenue
      $0.04m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ENTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ENTX Dividends
    All News

    NASDAQ RESUMED AT 10:34 AM

    Picture of Entera Bio logoEntera Bio
    23/06/2021 15:34
    NASDAQ RESUMED  ENTX.O  AT 10:34 AM
    

    Recent news on Entera Bio

    See all news
    • Brief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation

      18/08/2026 13:04
    • Corrected: Israel's Entera Bio Q2 net loss widens

      07/08/2026 21:31
    • NASDAQ RESUMED AT 10:02 AM

      27/07/2026 15:02
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM

      27/07/2026 14:57
    • Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement

      27/07/2026 14:07

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.